Björklund Pharma develops therapies to restore function, improve quality of life, and support the body’s natural healing processes. Guided by research on chronic, debilitating, and life-threatening conditions, the company focuses on defined product candidates as part of a disciplined strategy to address health challenges responsibly and collaboratively.

Björklund Pharma AS is a privately held, early-stage biopharmaceutical company based in Mo i Rana, northern Norway, and wholly owned by Bolna AS. Led by Geir Bjørklund, MD, it advances healthcare through evidence-based product development using biofactors and natural compounds. Through scientific and strategic innovation, the company aims to address complex medical challenges and improve patient outcomes.